391 related articles for article (PubMed ID: 17562377)
1. Mice deficient in cystathionine beta synthase display altered homocysteine remethylation pathway.
Alberto JM; Hamelet J; Noll C; Blaise S; Bronowicki JP; Guéant JL; Delabar JM; Janel N
Mol Genet Metab; 2007 Aug; 91(4):396-8. PubMed ID: 17562377
[TBL] [Abstract][Full Text] [Related]
2. Hyperhomocysteinemia due to cystathionine beta synthase deficiency induces dysregulation of genes involved in hepatic lipid homeostasis in mice.
Hamelet J; Demuth K; Paul JL; Delabar JM; Janel N
J Hepatol; 2007 Jan; 46(1):151-9. PubMed ID: 17030070
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation status is not impaired in treated cystathionine beta-synthase (CBS) deficient patients.
Heil SG; Riksen NP; Boers GH; Smulders Y; Blom HJ
Mol Genet Metab; 2007 May; 91(1):55-60. PubMed ID: 17336565
[TBL] [Abstract][Full Text] [Related]
4. Effect of methionine and nitrous oxide on homocysteine export and remethylation in fibroblasts from cystathionine synthase-deficient, cb1G, and cb1E patients.
Christensen B; Rosenblatt DS; Chu RC; Ueland PM
Pediatr Res; 1994 Jan; 35(1):3-9. PubMed ID: 8134195
[TBL] [Abstract][Full Text] [Related]
5. Hyperkeratosis in cystathionine beta synthase-deficient mice: an animal model of hyperhomocysteinemia.
Robert K; Maurin N; Ledru A; Delabar J; Janel N
Anat Rec A Discov Mol Cell Evol Biol; 2004 Oct; 280(2):1072-6. PubMed ID: 15386278
[TBL] [Abstract][Full Text] [Related]
6. Long-term betaine therapy in a murine model of cystathionine beta-synthase deficient homocystinuria: decreased efficacy over time reveals a significant threshold effect between elevated homocysteine and thrombotic risk.
Maclean KN; Jiang H; Greiner LS; Allen RH; Stabler SP
Mol Genet Metab; 2012 Mar; 105(3):395-403. PubMed ID: 22192524
[TBL] [Abstract][Full Text] [Related]
7. [From gene to disease; from homocysteine to hyperhomocysteinemia].
Boers GH
Ned Tijdschr Geneeskd; 2001 May; 145(20):956-8. PubMed ID: 11396261
[TBL] [Abstract][Full Text] [Related]
8. Homocysteine threshold value based on cystathionine beta synthase and paraoxonase 1 activities in mice.
Hamelet J; Aït-Yahya-Graison E; Matulewicz E; Noll C; Badel-Chagnon A; Camproux AC; Demuth K; Paul JL; Delabar JM; Janel N
Eur J Clin Invest; 2007 Dec; 37(12):933-8. PubMed ID: 17971175
[TBL] [Abstract][Full Text] [Related]
9. Genetic background conversion ameliorates semi-lethality and permits behavioral analyses in cystathionine beta-synthase-deficient mice, an animal model for hyperhomocysteinemia.
Akahoshi N; Kobayashi C; Ishizaki Y; Izumi T; Himi T; Suematsu M; Ishii I
Hum Mol Genet; 2008 Jul; 17(13):1994-2005. PubMed ID: 18364386
[TBL] [Abstract][Full Text] [Related]
10. Taurine-deficient diet up-regulated cystathionine beta-synthase monoallele in hemizygous cystathionine beta-synthase knockout mice.
Chao WH; Reynolds RD
Nutr Res; 2009 Nov; 29(11):794-801. PubMed ID: 19932868
[TBL] [Abstract][Full Text] [Related]
11. Homocystinuria: pathogenetic mechanisms.
Grieco AJ
Am J Med Sci; 1977; 273(2):120-32. PubMed ID: 324277
[TBL] [Abstract][Full Text] [Related]
12. Cystathionine beta-synthase mutations in homocystinuria.
Kraus JP; Janosík M; Kozich V; Mandell R; Shih V; Sperandeo MP; Sebastio G; de Franchis R; Andria G; Kluijtmans LA; Blom H; Boers GH; Gordon RB; Kamoun P; Tsai MY; Kruger WD; Koch HG; Ohura T; Gaustadnes M
Hum Mutat; 1999; 13(5):362-75. PubMed ID: 10338090
[TBL] [Abstract][Full Text] [Related]
13. [Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease?. 1. Basic data].
Guilland JC; Favier A; Potier de Courcy G; Galan P; Hercberg S
Pathol Biol (Paris); 2003 Mar; 51(2):101-10. PubMed ID: 12801808
[TBL] [Abstract][Full Text] [Related]
14. Derangement of hepatic polyamine, folate, and methionine cycle metabolism in cystathionine beta-synthase-deficient homocystinuria in the presence and absence of treatment: Possible implications for pathogenesis.
Maclean KN; Jiang H; Phinney WN; Mclagan BM; Roede JR; Stabler SP
Mol Genet Metab; 2021 Feb; 132(2):128-138. PubMed ID: 33483253
[TBL] [Abstract][Full Text] [Related]
15. The effect of dietary modulation of sulfur amino acids on cystathionine β synthase-deficient mice.
Kruger WD; Gupta S
Ann N Y Acad Sci; 2016 Jan; 1363(1):80-90. PubMed ID: 26599618
[TBL] [Abstract][Full Text] [Related]
16. Defective remethylation of homocysteine is related to decreased synthesis of coenzymes B2 in thyroidectomized rats.
Ayav A; Alberto JM; Barbe F; Brunaud L; Gerard P; Merten M; Gueant JL
Amino Acids; 2005 Feb; 28(1):37-43. PubMed ID: 15645165
[TBL] [Abstract][Full Text] [Related]
17. The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease.
Jakubowski H
J Physiol Pharmacol; 2008 Dec; 59 Suppl 9():155-67. PubMed ID: 19261978
[TBL] [Abstract][Full Text] [Related]
18. Contrasting behaviors of mutant cystathionine beta-synthase enzymes associated with pyridoxine response.
Chen X; Wang L; Fazlieva R; Kruger WD
Hum Mutat; 2006 May; 27(5):474-82. PubMed ID: 16619244
[TBL] [Abstract][Full Text] [Related]
19. Modulation of cystathionine beta-synthase level regulates total serum homocysteine in mice.
Wang L; Jhee KH; Hua X; DiBello PM; Jacobsen DW; Kruger WD
Circ Res; 2004 May; 94(10):1318-24. PubMed ID: 15105297
[TBL] [Abstract][Full Text] [Related]
20. Homocysteine: overview of biochemistry, molecular biology, and role in disease processes.
Fowler B
Semin Vasc Med; 2005 May; 5(2):77-86. PubMed ID: 16047261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
